The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold under the brand name Rasonque. It was approved for patients who already tried...
The Food and Drug Administration (FDA) on Wednesday approved a treatment for advanced pancreatic cancer, offering new life-extending care for patients with one of the most aggressive forms of cancer. The once-daily pill, called daraxonrasib and manufactured by Revolution Medicines, will be sold under the brand name Rasonque. It was approved for patients who already tried...
<iframe src="https://statesidedaily.com/embed/cluster/7693cc82f1ef1d7888214269d2d4c0dabfea73fb" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA approves groundbreaking new pancreatic cancer drug"></iframe>
